Female Viagra To Help Women Increase Sexual Arousal

A female equivalent of Viagra could soon be available to help women achieve the Big O, claim scientists. A team working for Pfizer Inc, the pharmaceutical firm behind Viagra, in Sandwich Kent has uncovered a substance that boosts female sexual arousal, increasing the chance of orgasm.

Viagra, lots of it. Will Pfizer soon have an analogous pink pill for women? Photo: Pfizer

The female equivalent of Viagra could soon be available to help women achieve the Big O, claim scientists.  A team working for Pfizer Inc – the company that discovered Viagra’s sexual effects by chance while searching for a treatment for high blood pressure and angina – has uncovered a substance that boosts female sexual arousal, increasing the chance of orgasm.

However, the studies are only in the animal stage, which means they are very preliminary. The findings could pave the way for a drug similar in effect to Viagra. In the study, using a novel prototype drug, researchers discovered more about the mechanisms underlying female sexual arousal.

The boffins found that electrically stimulating the pelvic nerve increases blood flow to the genitalia, and that this effect was enhanced if they also gave a prototype drug. They believe that the drug acts by blocking the breakdown of an internal chemical messenger that plays a key role in increasing blood flow during sexual arousal.

When women become aroused, blood flow increases to the vagina, labia and clitoris. This causes the organs to swell, and the vagina to relax, as well as increasing vaginal lubrication and the sensitivity of the genitalia.

Female sexual arousal disorder (FSAD) affects up to 40% of women irrespective of age. These women find that their genital organs do not respond to sexual stimulation, they find arousal difficult and this causes them to become distressed.

“Before this work, we knew surprisingly little about the processes that control all of these changes,” says the lead researcher in the project Chris Wayman. “Now we are beginning to establish the pathways involved in sexual arousal scientists may be able to find ways of helping women who would like to overcome FSAD.”

In the study, researchers stimulated the pelvic nerve and measured changes in genital organs.  The genital arousal occurred because stimulation of the nerve triggered the release of vasoactive intestinal peptide (VIP), a well-known neurotransmitter. VIP has only a short-lived effect, because it is soon broken down by an enzyme called Neutral Endopeptidase (NEP).

The researchers believe that their prototype drug increased the arousal because it blocked NEP’s ability to break down VIP, therefore letting the VIP have a more powerful and prolonged effect increasing arousal. [via LA Times and Portfolio]

Share this article

We welcome comments that advance the story directly or with relevant tangential information. We try to block comments that use offensive language, all capital letters or appear to be spam, and we review comments frequently to ensure they meet our standards. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Coinspeaker Ltd.